MGMT and central nervous system cancer: However, there are many studies in the literature for other organs, including breast oncology [134] imaging (e.g., miRNAs expression, gene expression and Ki67 proliferation index), and for brain imaging (Supplementary Figure S1), including biomarkers such as isocitrate dehydrogenase (IDH) [135], chromosome arms 1p/19q-codeletion [136,137,138] and methylguanine-DNA methyltransferase status (MGMT) [139,140,141,142] as prognostic markers for glioma [143,144,145].